Scale up: De-risking financing and meeting capital needs (Part II of II)
Alternative protein production is capital-intensive, requiring large upfront investment for production facilities and equipment. Unlike more established industries with such needs, funding the scale-up of alternative proteins can be higher risk for investors due to the sector’s nascency. Join us for a series of mini-presentations that cover how techno-economic analyses (TEAs) and data, risk-mitigating financial and business structures, and public and sustainable financing can de-risk and meet this critical investment need.
Speakers:
Sharyn Murray, Investor Engagement Manager, Good Food Institute (moderator/presenter)
Brentan Alexander, Ph.D., Chief Investment Officer, Synonym
Matt Lucas, Ph.D., Managing Partner, Tuatara Development Capital
Christina Sewell, ESG Analyst, S&P Global
Catherine Tubb, Ph.D., Director of Research, Synthesis Capital
Session slide deck: https://drive.google.com/file/d/1q5YU...